Participants indicated that WMG-E could empower clinicians and parents by enhancing health literacy about child developmental issues, but that it could also be disempowering if not used carefully.

Once considered rare, Gilles de la Tourette syndrome is now understood to be relatively common, occurring in approximately 1% of school-aged children.